§ Mr. Connarty
To ask the Secretary of State for Health whether a safer recombinant treatment product will be made available to haemophilia sufferers in England and Northern Ireland. 
§ Mr. Hutton
We are actively considering extending the provision of recombinant clotting factors to all haemophilia patients in England when supplies allow. Currently the policy is to provide recombinant (synthetic) clotting factors for new haemophilia patients and children under 16.
Questions relating to Northern Ireland are a matter for the devolved Administration.